WeInfuse

WeInfuse

SaaS platform for infusion center management

Overview

WeInfuse provides a web-based software platform for infusion centers that treat specialty biologic medications. The platform centralizes key operations in one system, including scheduling, inventory management, billing, and compliance tracking, and is delivered on a subscription basis. How it works: healthcare staff use the cloud app to schedule patient infusions, manage medicine stock, bill for services, and ensure regulatory compliance, with data synchronized across the center to reduce administrative work and improve patient care. How it differs from competitors: it focuses specifically on under-resourced infusion centers handling biologic therapies, offering an end-to-end management tool in a single subscription product, which helps centers run more efficiently and control costs. Goal: enable infusion centers to operate smoothly, lower operational costs, and deliver better patient outcomes while serving the growing market for specialty biologics.

Significant Headcount Growth

About WeInfuse

Simplify's Rating
Why WeInfuse is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Enterprise Software

Healthcare

Company Size

51-200

Company Stage

Growth Equity (Venture Capital)

Total Funding

N/A

Headquarters

Austin, Texas

Founded

2016

Get referred to WeInfuse

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • WeInfuse reported 189% growth from 2023 to 2025 and roughly 50% 2026 growth.
  • June-August 2026 partnerships expand addressable spend into intake, pumps, research, and supply chain.
  • More than 1,500 customers versus 625 in 2023 signals strong network effects and referrals.

What critics are saying

  • Competitors like Cencora, TailorMed, and distributor portals can disintermediate WeInfuse by 2027.
  • Healthcare software remains integration-heavy; one failed payer, device, or EHR rollout damages retention.
  • If reimbursement automation stalls, WeInfuse stays a workflow layer, not the system of record.

What makes WeInfuse unique

  • WeInfuse spans scheduling, inventory, billing, claims, and compliance across 1,500+ sites by 2026.
  • Partnerships with Eitan Medical, BioCareSD, 4U Medical, and VETRIQ deepen workflow stickiness.
  • InfuseTrack and RxToolKit broaden WeInfuse beyond core EMR into assets and training.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Vacation

Paid Parental Leave

401(k) Retirement Plan

Phone/Internet Stipend

Growth & Insights and Company News

Headcount

6 month growth

↑ 13%

1 year growth

↑ 13%

2 year growth

↑ 13%
Dallas Next
Sep 1st, 2026
WeInfuse marks 10th anniversary with triple-digit growth and a partnership playbook.

WeInfuse marks 10th anniversary with triple-digit growth and a partnership playbook. Celebrating its "Golden Decade," the Dallas- and Austin-based medical software provider climbed to its highest-ever Inc. 5000 ranking and notched its fourth straight year on the Longhorn 100. WeInfuse's Dallas team celebrates its recent growth milestone, which landed it on the Inc. 5000. [Photo: WeInfuse] Ten years after its launch, Dallas- and Austin-based medical software provider WeInfuse has climbed to its highest-ever ranking on the Inc. 5000. Part of the growth equation: lean on partnerships to incorporate tech from other companies. "Our goal is for WeInfuse to be the system of record and technology backbone for infusion providers and pharmacies - not necessarily to build every piece of technology they will ever use," Reece Norris, co-founder, president and chief operating officer, told Dallas Innovates. Norris said WeInfuse seeks to retain core capabilities of its software platform, such as scheduling, inventory and claims management. But beyond those capabilities, the company turns to partners' technology. For instance, WeInfuse recently connected its clinical and claims workflows to technology and hardware from New Jersey-based 4U Medical. Offerings from 4U Medical include check-in kiosks and tablets, and electronic insurance validation. "Ultimately, we want our clients to have fewer disconnected systems and less duplicate data entry," Norris said. Making the Inc. 5000 and Longhorn 100 Tech partnerships contribute to the company's noteworthy trajectory. WeInfuse landed on this year's Inc. 5000 list of the country's fastest-growing private companies. WeInfuse appeared at No. 1,834 with a 189% growth rate from 2023 to 2025. That's the highest ranking for WeInfuse since it debuted on the Inc. 5000 in 2023. The company's Dallas office primarily handles sales, marketing and finance matters, Norris said. The Austin office works mostly on software development and client success. Also in 2026, WeInfuse accomplished the same four-in-a-row streak in the Texas Exes' Longhorn 100 program. The program recognizes the 100 fastest-growing businesses founded, owned or led by University of Texas at Austin alumni. WeInfuse ranked 41st this year. Norris received a UT law degree in 2006. Josh Newman, the chief financial officer, earned a bachelor's degree in economics from UT in 2003. Norris said the Longhorn 100 and Inc. 5000 recognition aligns with a company mantra: "Consistency compounds." He declined to provide WeInfuse's total revenue. But Norris said the company expects to post roughly 50% year-over-year growth in 2026. The 'Golden Decade' WeInfuse calls its first 10 years in business the "Golden Decade." Today, more than 1,500 infusion centers and pharmacies in the U.S. use WeInfuse software, up from more than 625 in 2023. "WeInfuse has experienced tremendous growth over the last several years, but we've been intentional about growing responsibly," Norris said. Three years ago, WeInfuse gained an undisclosed amount of growth funding from Curewell Capital, a Los Angeles-based private equity firm. The firm invests in North American health care companies. Acquisitions and integrations on the table Since the Curewell investment, WeInfuse has expanded its workforce to 80, Norris said. It also built out claims management capabilities, added home infusion and specialty pharmacies to its offerings. Further, it rebuilt its RxToolKit clinical and safety education software, and launched InfuseTrack. InfuseTrack helps infusion providers manage pumps, medical equipment and certifications. WeInfuse won't need to raise more capital to execute its strategy, said Norris. But the company would consider acquisitions beyond its 2022 purchase of RxToolKit. In addition, WeInfuse sees opportunities to accelerate its roadmap through automation, AI, improved data connectivity and tech integrations, he said. "The next frontier is making... workflows increasingly connected, intelligent and automated," Norris said. "There are still far too many manual processes involved in getting a patient from referral to treatment to payment."

PR Newswire
Aug 26th, 2026
WeInfuse partners with 4U Medical to streamline infusion patient check-in and care delivery

WeInfuse, a software platform for infusion providers and pharmacies, has partnered with 4U Medical to streamline patient intake and treatment processes. The integration connects 4U Medical's check-in kiosks, insurance validation, and patient engagement features with WeInfuse's clinical and claims workflows. The partnership enables bidirectional data exchange between the two platforms, aiming to reduce administrative costs, staff burnout, and data entry errors. FloMed Infusion, a multi-site provider in Florida, was among the first to implement the integration. According to FloMed's CFO Danny Winter, the self-check-in kiosk has streamlined front desk operations whilst collecting valuable patient information. The integration automates patient intake and check-in processes, allowing infusion centres and pharmacies to standardise patient touchpoints from arrival through post-visit engagement.

PR Newswire
Jun 2nd, 2026
WeInfuse partners with Trial IQ to bring AI-driven clinical research to infusion providers

WeInfuse, a software platform for infusion providers and specialty pharmacies, has partnered with Trial IQ Technologies to bring AI-driven clinical research capabilities to infusion centres. The collaboration enables infusion providers to launch and manage clinical trial programmes using their existing infrastructure. Trial IQ, founded by Brian Zweben, Cerdi Beltre and Sury Gupta, automates trial matching, patient identification, site readiness and physician education. The platform helps community practices and infusion centres conduct research without disrupting existing clinical operations. The integration provides WeInfuse clients with operational tools and workflows to participate in clinical trials. Trial IQ aims to expand access to clinical research beyond large academic centres, bringing cutting-edge therapies and research opportunities directly to community-based care environments whilst maintaining operational efficiency.

WeInfuse
May 19th, 2026
Press release: biocaresd announces strategic partnership with WeInfuse to expand infusion practice technology capabilities.

Press release: biocaresd announces strategic partnership with WeInfuse to expand infusion practice technology capabilities. * WeInfuse Guest * May 19, 2026 Tempe, AZ - May 19, 2026 - BioCareSD, a BioCare company and national specialty distributor, today announced a new partnership with WeInfuse, a leading infusion management technology platform used by providers across more than 1,300 locations nationwide. The collaboration will enable closer integration between BioCareSD and WeInfuse customers while expanding BioCareSD's technology-enabled offerings for infusion practices and pharmacies. WeInfuse delivers a comprehensive workflow management platform for infusion providers, supporting patient management, treatment workflows, patient and margin estimation, scheduling, inventory management, and billing & claims. Through this partnership, BioCareSD will integrate closely with the WeInfuse software to streamline ordering, visibility, and coordination - helping providers operate more efficiently while staying focused on patient care. "We're excited to partner with WeInfuse to support infusion providers with smarter, more connected technology," said Cory Shouse, CIO BioCare. "This partnership reflects our ongoing commitment to operational excellence and to meeting customers where they are - by integrating seamlessly into the systems they already rely on." WeInfuse offers distributor connectivity designed to simplify the procurement and fulfillment process, including electronic ordering, product availability checks, order and shipment confirmations, fulfillment status updates at both order and line levels, and shipment tracking visibility within the platform. The integration will embed BioCareSD's extensive portfolio of specialty and hard-to-source therapies directly into the WeInfuse workflow, enabling streamlined ordering, real-time visibility into product availability, and operational insights that help infusion centers and pharmacies operate more efficiently. Customers retain the flexibility to place orders either directly within the WeInfuse platform or through their existing ordering workflows outside the platform. "By working closely with BioCareSD, we're expanding the value we deliver to our users through improved integration and coordination across the supply chain," said Bryan Johnson, WeInfuse Co-Founder. "Together, we're focused on helping infusion providers reduce complexity and improve operational visibility." The partnership builds on BioCareSD's purpose-built, specialty-only distribution model, leveraging technology designed to strengthen alignment with customer workflows and support reliable, data-informed decision-making. As infusion practices continue to grow and evolve, the integration helps deliver a more connected experience across clinical, financial, and operational functions - enhancing efficiency while preserving the high-touch partnership and service BioCareSD is known for. With this partnership, BioCareSD continues to demonstrate its commitment to meeting customers where they want WeInfuse, LLC to be, enabling seamless, integrated transactions within their existing workflows. About BioCareSD BioCareSD, a BioCare company, is a national specialty distributor with nearly 50 years of experience delivering life-changing specialty therapies. BioCareSD has reimagined specialty distribution focusing on trust, transparency, and operational excellence. The company provides high-touch, personalized service through a dedicated support team and 24/7/365 customer care. Its distribution model and expanding portfolio support partners in their mission to improve patients' lives. Learn more at biocaresd.com. About WeInfuse WeInfuse is the premier technology and consulting provider for infusion therapy and medication delivery in the U.S. The WeInfuse software platform powers the end-to-end workflow for infusion centers and home infusion and specialty pharmacies nationwide. WeInfuse's modern, purpose-built workflows for all sites of care allow pharmacies and providers to improve patient care and scale operations with confidence. Take the confusion out of infusion and learn more at weinfuse.com. WeInfuse needs the contact information you provide to WeInfuse, LLC to contact you about its products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as its privacy practices and commitment to protecting your privacy, please review its Privacy Policy.

PR Newswire
Mar 26th, 2026
WeInfuse launches InfuseTrack to streamline infusion asset management with real-time tracking and compliance

WeInfuse has launched InfuseTrack, a software platform designed to streamline facility, equipment and licence management for infusion centres, specialty pharmacies and home infusion providers. The platform provides real-time tracking of infusion pumps and medical devices across multiple locations, replacing manual spreadsheets and logs. InfuseTrack offers automated maintenance alerts, digital chain-of-custody documentation and instant audit-ready compliance records. The system aims to address costly issues including misplaced equipment, missed calibration deadlines and failed audits that plague infusion providers managing device fleets across multiple sites. The platform includes customisable workflows, inventory monitoring and environmental tracking for medication storage. WeInfuse CEO Bryan Johnson said the solution brings accountability whilst reducing equipment losses and simplifying compliance management. The platform is now available to infusion therapy operators.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for WeInfuse right now.

Find jobs on Simplify and start your career today

We update WeInfuse's jobs every few hours, so check again soon! Browse all jobs →